Product Information
ASPIRIN EC 81 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0142 per EA under NDC 57237034910. Its NADAC has been published 36 times since Jan 28, 2026.
Strength
81 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237034910
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ASPIRINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
7/9/2025
Pharmacological Classes
Price Statistics
The NADAC for ASPIRIN EC 81 MG TABLET has been published 36 times since Jan 28, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0142 per EA |
|---|---|
| All-time high | $0.0147 (May 13, 2026) |
| All-time low | $0.0142 (Jan 28, 2026) |
| 52-week high | $0.0147 |
| 52-week low | $0.0142 |
| Median price | $0.0144 |
| Average price | $0.0144 |
| Largest weekly change | -2.5% (Sep 23, 2026) |
| Weeks tracked | 36 |
| Tracking since | Jan 28, 2026 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Aspirin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ASPIRIN EC 81 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ASPIRIN EC 81 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0142 per EA (NDC 57237034910), effective Sep 30, 2026.
How has the price of ASPIRIN EC 81 MG TABLET changed over time?
Over the history we have for it, the NADAC for ASPIRIN EC 81 MG TABLET has held within roughly two percent of its current level. It has been tracked across 36 weekly CMS publications since Jan 28, 2026.
What are the highest and lowest recorded NADAC prices for ASPIRIN EC 81 MG TABLET?
Since Jan 28, 2026, the NADAC for ASPIRIN EC 81 MG TABLET has ranged from a low of $0.0142 (Jan 28, 2026) to a high of $0.0147 (May 13, 2026), with a median of $0.0144 per EA.
Are there cheaper alternatives to ASPIRIN EC 81 MG TABLET?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MINIPRIN EC 81 MG TABLET, is $0.0118 per EA — about 17% below ASPIRIN EC 81 MG TABLET.
Who manufactures ASPIRIN EC 81 MG TABLET?
ASPIRIN EC 81 MG TABLET (NDC 57237034910) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.